Ticker > Company >

Fortis Healthcare share price

Fortis Healthcare Ltd.

NSE: FORTIS BSE: 532843 SECTOR: Hospital & Healthcare Services  2.29 L   651   135

912.70
-2.05 (-0.22%)
NSE: Today, 10:34 AM

Price Summary

Today's High

₹ 919.9

Today's Low

₹ 904.1

52 Week High

₹ 1104.3

52 Week Low

₹ 577

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

68905.03 Cr.

Enterprise Value

70634.17 Cr.

No. of Shares

75.5 Cr.

P/E

395.33

P/B

7.51

Face Value

₹ 10

Div. Yield

0.11 %

Book Value (TTM)

₹  121.53

CASH

49.45 Cr.

DEBT

1778.59 Cr.

Promoter Holding

31.17 %

EPS (TTM)

₹  2.31

Sales Growth

22.39%

ROE

0.7 %

ROCE

2.23%

Profit Growth

-68.02 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Fortis Healthcare Ltd.

SRL La-femme

Index Presence

The company is present in 39Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year22.39%
3 Year18.79%
5 Year15.55%

Profit Growth

1 Year-68.02%
3 Year89.58%
5 Year-34.1%

ROE%

1 Year0.7%
3 Year1.33%
5 Year0.78%

ROCE %

1 Year2.23%
3 Year2.67%
5 Year2.2%

Debt/Equity

0.196

Price to Cash Flow

206.29

Interest Cover Ratio

2.0254

CFO/PAT (5 Yr. Avg.)

2.4521079040015

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2025 31.17 0.00
Jun 2025 31.17 0.00
Mar 2025 31.17 0.00
Dec 2024 31.17 0.00
Sep 2024 31.17 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 89.5807839611589% for the Past 3 years.
  • The company has shown a good revenue growth of 18.7877863928583% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of -527.2477 days.
  • The company has a good cash flow management; CFO/PAT stands at 2.4521079040015.

 Limitations

  • Company has a poor ROE of 1.33056666666667% over the past 3 years.
  • Company has a poor ROCE of 2.67363333333333% over the past 3 years
  • The company is trading at a high PE of 395.33.
  • The company is trading at a high EV/EBITDA of 137.2164.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Net Sales 357.15 366.87 388.47 433.03 455.81
Total Expenditure 297.3 300.11 317.51 344.92 355.93
Operating Profit 59.85 66.76 70.96 88.11 99.88
Other Income 104.17 33.96 24.99 40.01 92.42
Interest 16.32 26.51 51.91 51.87 50.67
Depreciation 27.41 28.96 30.52 30.16 28.48
Exceptional Items -68.28 5.56 -52.42 16.88 21.83
Profit Before Tax 52.01 50.81 -38.9 62.97 134.98
Tax 12.38 11.25 3.33 11.09 9.89
Profit After Tax 39.63 39.56 -42.23 51.88 125.09
Adjusted EPS (Rs) 0.52 0.52 -0.56 0.69 1.66

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 632.87 862.61 1052.93 1181.42 1445.89
Total Expenditure 604.96 747.21 919.78 988.62 1190.38
Operating Profit 27.91 115.41 133.15 192.81 255.5
Other Income 191.98 134.09 149.58 143 198.55
Interest 141.45 129.58 106.24 81.92 111.58
Depreciation 110.77 112.63 115.88 100.98 112.92
Exceptional Items 56.46 -16.28 48.29 93.65 -115.14
Profit Before Tax 24.13 -8.99 108.88 246.56 114.41
Tax 19.93 4.26 12.64 47.11 50.63
Net Profit 4.2 -13.25 96.24 199.45 63.78
Adjusted EPS (Rs.) 0.06 -0.18 1.27 2.64 0.84

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 754.96 754.96 754.96 754.96 754.96
Total Reserves 8126.57 8113.61 8208.58 8332.21 8319.04
Borrowings 663.78 585.52 281.58 254.05 1738.19
Other N/C liabilities 732.48 682.92 556.38 522.29 479.05
Current liabilities 472.51 462.74 644.66 760.13 994.7
Total Liabilities 10750.31 10599.75 10558.48 10623.65 12285.94
Assets
Net Block 852.83 770.28 491.86 467.31 924.97
Capital WIP 6.32 6.33 2.67 259.38 42.32
Intangible WIP 0.42 0 0 0.82 0.07
Investments 8898.47 8845.29 8847.6 8834.04 10178.25
Loans & Advances 605.51 570.78 525.56 420.23 750.14
Other N/C Assets 1.31 1.38 256.36 0.37 0.25
Current Assets 385.44 405.69 434.42 641.5 389.93
Total Assets 10750.31 10599.75 10558.48 10623.65 12285.94
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 24.13 -8.99 108.88 246.56 114.41
Adjustment 24.6 123.55 27.6 -46.82 149.3
Changes in Assets & Liabilities -7.28 10.72 95.53 41.77 68.28
Tax Paid -9.5 -48.79 -33.64 -23.06 2.03
Operating Cash Flow 31.94 76.49 198.38 218.45 334.02
Investing Cash Flow 28.4 237.74 204.62 44.46 -1572.21
Financing Cash Flow 5.91 -319.83 -395.43 -245.35 1275.91
Net Cash Flow 66.26 -5.6 7.57 17.56 37.72

Corporate Actions

Investors Details

PARTICULARS Sep 2024% Dec 2024% Mar 2025% Jun 2025% Sep 2025%
promoters 31.17 31.17 31.17 31.17 31.17
northern tk venture pte. ... - - 31.17 31.17 31.17
northern tk venture pte.l... - 31.17 - - -
northern tk venture pte. ... 31.17 - - - -
PARTICULARS Sep 2024% Dec 2024% Mar 2025% Jun 2025% Sep 2025%
investors 68.83 68.83 68.83 68.83 68.83
aditya birla sun life tru... 3.47 2.97 2.46 2.47 1.84
amansa holdings private l... 1.41 1.41 1.70 1.70 1.70
axis bank limited 1.19 1.19 1.19 1.19 1.19
axis elss tax saver fund - - - 3.40 3.40
bnp paribas financial mar... - - - - 1.07
dsp nifty healthcare etf - - - 1.29 1.29
edelweiss trusteeship co ... - - - - 1.10
fidelity funds - india fo... 1.67 - 1.62 1.64 1.40
government pension fund g... 1.23 1.14 - 1.04 1.04
hdfc mutual fund-hdfc arb... - - - 5.68 6.01
jupiter india fund 1.86 1.81 1.52 1.38 1.38
kotak debt hybrid - - - - 4.81
kotak funds - india midca... 1.28 - 1.24 1.24 1.21
nippon life india trustee... - - - - 2.36
rekha jhunjhunwala 4.07 4.07 4.07 4.07 4.07
sbi life insurance co. lt... - - 1.53 1.55 1.51
societe generale - odi - - - - 1.11
edelweiss business cycle ... - - - 1.01 -
kotak equity hybrid - - - 5.14 -
nippon life india trustee... - - - 2.38 -
axis mutual fund trustee ... 3.29 3.46 3.40 - -
dsp equity opportunities ... - - 1.29 - -
hdfc mutual fund - hdfc s... - 5.86 6.00 - -
kotak emerging equity sch... - - 4.56 - -
mirae asset nifty midcap ... 1.77 - 1.33 - -
nippon life india trustee... 2.37 - 2.28 - -
fidelity funds-india focu... - 1.72 - - -
kotak funds-india midcap ... - 1.27 - - -
kotak mahindra trustee co... - 4.40 - - -
mire asset elss tax saver... - 1.54 - - -
nippon life india trustee... - 2.40 - - -
sbi life insurance co.ltd... 1.42 1.40 - - -
sbi long term equity fund... 1.11 1.15 - - -
hdfc mutual fund - hdfc n... 5.56 - - - -
kotak mahindra trustee co... 5.28 - - - -
sundaram mutual fund a/c ... 1.13 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit ICRA
Credit CRISIL
Credit CRISIL
Credit CARE
TYPE AGENCY Link
TYPE AGENCY Link
Research HDFC Securities
Research HDFC Securities
Research HDFC Securities
Research Ventura
Research Way2Wealth

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q4FY23
Concall Q4FY22
Concall Q3FY25
Concall Q3FY24
Concall Q3FY20
Concall Q2FY24
Concall Q2FY21
Concall Q1FY25
Concall Q1FY24
Concall Q1FY21
Concall Q1FY20
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q4FY20
Presentation Q3FY25
Presentation Q3FY24
Presentation Q2FY24
Presentation Q2FY21
Presentation Q1FY25
Presentation Q1FY24
Presentation Q1FY24
Presentation Q1FY21
Presentation Q1FY20

Company News

Fortis Healthcare inks pact to acquire People Tree Hospital in Bengaluru 20 Dec, 10:23 AM Fortis Healthcare informs about press release 20 Dec, 9:55 AM Fortis Healthcare informs about disclosure 20 Dec, 9:54 AM Fortis Healthcare informs about change in directors 19 Dec, 4:05 PM Fortis Healthcare informs about newspaper advertisements 17 Oct, 2:59 PM Fortis Healthcare informs about press release 16 Oct, 3:23 PM Fortis Healthcare to invest over Rs 900 crore in Punjab 20 Sep, 11:06 AM Fortis Healthcare’s arm inks lease agreement with RR Lifesciences 2 Sep, 9:15 AM Fortis Healthcare signs collaboration agreement with Ekana Group 21 Aug, 9:16 AM Fortis Healthcare - Quaterly Results 6 Aug, 12:00 PM Fortis Healthcare - Quaterly Results 6 Aug, 12:00 PM Fortis Healthcare enters into O&M services agreement with GHIPL 23 Jul, 3:44 PM Fortis Healthcare informs about dividend payment 14 Jul, 5:37 PM Fortis Healthcare reports 7% fall in Q4 consolidated net profit 21 May, 2:23 PM Fortis Healthcare - Quaterly Results 20 May, 7:19 PM Fortis Healthcare - Quaterly Results 20 May, 7:19 PM Fortis Healthcare informs about reporting of debt securities 10 Apr, 11:54 AM Fortis Healthcare’s arm to acquire entire business operations of Shrimann Superspecialty Hospital 14 Feb, 4:25 PM Fortis Healthcare - Quaterly Results 7 Feb, 6:00 PM Fortis Healthcare - Quaterly Results 7 Feb, 6:00 PM Fortis Healthcare acquires 7.61% stake in Agilus Diagnostics 21 Dec, 12:29 PM Fortis Healthcare informs about outcome of committee meeting 19 Dec, 4:34 PM Fortis Healthcare - Quaterly Results 8 Nov, 5:32 PM Fortis Healthcare - Quaterly Results 8 Nov, 5:32 PM Fortis Healthcare - Quaterly Results 8 Nov, 5:32 PM Fortis Healthcare informs about change in directorate 23 Sep, 12:13 PM Fortis Healthcare informs about earnings call transcript 12 Aug, 1:32 PM Fortis Healthcare informs about disclosure 7 Aug, 12:14 PM Fortis Healthcare - Quaterly Results 6 Aug, 8:22 PM Fortis Healthcare - Quaterly Results 6 Aug, 8:22 PM Fortis Healthcare reports 47% rise in Q4 consolidated net profit 24 May, 2:26 PM Fortis Healthcare - Quaterly Results 23 May, 7:10 PM Fortis Healthcare - Quaterly Results 23 May, 7:10 PM Fortis Healthcare informs about disclosure 23 Feb, 5:21 PM Fortis Healthcare - Quaterly Results 7 Feb, 7:45 PM Fortis Healthcare - Quaterly Results 7 Feb, 7:45 PM Fortis Healthcare’s arm sells business operations in Chennai to MGM 2 Feb, 11:45 AM Fortis Healthcare reports 16% fall in Q2 consolidated net profit 13 Nov, 12:42 PM Fortis Healthcare - Quaterly Results 10 Nov, 6:30 PM Fortis Healthcare - Quaterly Results 10 Nov, 6:30 PM Fortis Healthcare informs about disclosure 30 Sep, 10:33 AM Fortis Healthcare informs about change in directorate 13 Sep, 5:14 PM Fortis Healthcare informs about voting results 8 Sep, 5:11 PM Fortis Healthcare - Quaterly Results 4 Aug, 8:06 PM Fortis Healthcare - Quaterly Results 4 Aug, 8:06 PM Fortis Healthcare partners with emergency response network RED.Health 27 Jun, 3:07 PM Fortis Healthcare inks pact for sale of hospital business operations at Vadapalani 22 Jun, 3:42 PM Fortis Healthcare informs about investor meetings 5 Jun, 12:48 PM Fortis Healthcare informs about disclosure 1 Jun, 4:18 PM Fortis Healthcare reports 59% rise in Q4 consolidated net profit 24 May, 11:14 AM

Fortis Healthcare Stock Price Analysis and Quick Research Report. Is Fortis Healthcare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Fortis Healthcare. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Fortis Healthcare has a PE ratio of 396.218651188981 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Fortis Healthcare has ROA of 0.5568% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Fortis Healthcare has a Current ratio of 0.392.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Fortis Healthcare has a ROE of 0.7024%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Fortis Healthcare has a Debt to Equity ratio of 0.196 which means that the company has low proportion of debt in its capital.

  • Sales growth: Fortis Healthcare has reported revenue growth of 22.3851% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Fortis Healthcare for the current financial year is 17.6710717866564%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Fortis Healthcare is Rs 1 and the yield is 0.1093%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Fortis Healthcare is Rs 2.3087. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Fortis Healthcare in Ticker for free. Also, one can get the intrinsic value of Fortis Healthcare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Fortis Healthcare FAQs

Q1. What is Fortis Healthcare share price today?
Ans: The current share price of Fortis Healthcare is Rs 914.75.

Q2. What is the market capitalisation of Fortis Healthcare?
Ans: Fortis Healthcare has a market capitalisation of Rs 69059.7965883 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Fortis Healthcare?
Ans: The PE ratio of Fortis Healthcare is 396.218651188981 and the P/B ratio of Fortis Healthcare is 7.52692330478629, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Fortis Healthcare share?
Ans: The 52-week high share price of Fortis Healthcare is Rs 1104.3, and the 52-week low share price of Fortis Healthcare is Rs 577.

Q5. Does Fortis Healthcare pay dividends?
Ans: Currently, Fortis Healthcare pays dividends. Dividend yield of Fortis Healthcare is around 0.1093%.

Q6. What are the face value and book value of Fortis Healthcare shares?
Ans: The face value of Fortis Healthcare shares is Rs 10, while the book value per share of Fortis Healthcare is around Rs 121.5304. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Fortis Healthcare?
Ans: Fortis Healthcare has a total debt of Rs 1778.587 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Fortis Healthcare?
Ans: The ROE of Fortis Healthcare is 0.7024% and ROCE of Fortis Healthcare is 2.2314%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Fortis Healthcare a good buy for the long term?
Ans: The Fortis Healthcare long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Fortis Healthcare undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Fortis Healthcare appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Fortis Healthcare’s financials?
Ans: You can review Fortis Healthcare’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Fortis Healthcare
X